chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Diarrhoea, Dysphagia, Electrocardiogram QT prolonged, Encephalopathy
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endoscopy, Gastrointestinal oedema, Hepatic cirrhosis, Imaging procedure, Intestinal angioedema
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intestinal mass, Intracranial mass, Laboratory test, Leukocytosis, Malaise
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oesophageal varices haemorrhage, Peritonitis bacterial, Supraventricular tachycardia, Thrombosis
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Antiphospholipid antibodies, Antiphospholipid antibodies positive, Antiphospholipid syndrome, Asthenia
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Computerised tomogram abnormal, Death, Diarrhoea, Disorientation
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Disturbance in attention, Embolism, Fatigue, Gait disturbance, Gastritis
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: General physical health deterioration, Hypopnoea, Laboratory test abnormal, Musculoskeletal chest pain, Nausea
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pelvic discomfort, SARS-CoV-2 test negative, Vaccination complication, Vomiting
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 77.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Wheelchair user
Clinical narrative: Patient died on 2/27/2021 of Catastrophic Antiphospholipid syndrome at the Medical Center. She had no history of blood clots or of an autoimmune syndrome in Medical records. After the shot on 1/29/2021 patient self reported on 02/02/2021 "aches and palpitations in pelvis" Next day she noted "felt gastritus,,soreness under ribs and could not get a deep breath". Her condition continued to deteriorate and when she got diarrhea she called her doctor who recommended a Covid-19 test. Patient got that test on 02/10/2021 (negative result). Her condition continued to worsen adding new symptoms of vomiting and extreme tiredness. such that she got a doctors appointment for 02/15/2021.   On 02/15/2021 patient's condition deteriorated rapidly in the early afternoon before her appointment such that she was mentally disoriented and unable to concentrate; and was physically so weak and unsteady that she had to be assisted in her walking and needed a wheel chair by the time of the appointment. Patient was sent to the emergency room at Hospital and later transferred to Medical Center. Her admission notes at Medical Center list the first Assessment as Thrombus (pages of Electronic records). "Patient presents with concern for thrombus in both venous (splenic, SMV, portal vein) and arterial supplies (renal). --" Further on in paragraph entitled "Assessment and Plan" of the ER report at hospital the record says in part" "This is a 77 y.o. female with fatigue, nausea, vomiting. Found to have abdominal discomfort on examination. Labs and CT scans show multiple derangements. Etiology is uncertain. Most likely represents an embolic phenomenon of some kind." (Note that phenomenon can involve an autoimmune response.)   Patient had gone to the hospital ER on 10/20/2020. The medical records for that visit start including all lab tests. Essentially this all dealt with her lightheadedness and tachycardia. She had follow up visits on 10/23/2020; 11/17/2020 and finally on 01/26/2021. The doctor's report on that last visit noted with regard to the tachycardia that patient has been asymptomatic since using metoprolol succinate and noted any fatigue and lightheadedness may be due to medication and suggested cutting the dose in half. The hypertension was strongly suspected to be "white coat hypertension"; Osteopenia was stable and the cyst benign. There were no other medical conditions noted.   These facts prove that it is more likely than not that the Moderna Vaccine is the most likely cause of patient's embolic phenomenon or that the vaccine triggered an asymptomatic reaction causing the embolic phenomenon.  Please add a warning to Moderna Fact sheet for patients and providers to save a life!  SEEK IMMEDIATE MEDICAL ATTENTION IF YOU DEVELOP PERSISTENT ABDOMINAL PAIN; DIARRHEA; SHORTNESS OF BREATH; VOMITING; EXHAUSTION; OR MENTAL DISORIENTATION  TWO WEEKS after vaccination!
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Cold sweat, Hypotension, Palpitations
Clinical narrative: vasovagal response led to Afib with RVR  within 15 min of vaccine-- Pt transferred to ER by vaccination site
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Atrial fibrillation, Heart rate increased, Presyncope
Clinical narrative: vasovagal response led to Afib with RVR  within 15 min of vaccine-- Pt transferred to ER by vaccination site
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Severe stroke, which induced a fall when he was home alone.  Last spoke to someone early in the afternoon of the 11th, found unconscious the morning of the 12th, too late for surgical intervention.  Stroke on the left side of the brain, primary impact to communication centers, diagnosed with aphasia and apraxia.  Some impact on control of right side of his body.  Spent 47 days in the hospital back and forth between medical and rehab sides, and afterwards is doing outpatient rehab at another facility.  20 days after leaving hospital rehab he still has significant aphasia and apraxia, and reduced motor control, balance, etc.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Apraxia, Balance disorder, Cerebrovascular accident, Electrocardiogram
Clinical narrative: Severe stroke, which induced a fall when he was home alone.  Last spoke to someone early in the afternoon of the 11th, found unconscious the morning of the 12th, too late for surgical intervention.  Stroke on the left side of the brain, primary impact to communication centers, diagnosed with aphasia and apraxia.  Some impact on control of right side of his body.  Spent 47 days in the hospital back and forth between medical and rehab sides, and afterwards is doing outpatient rehab at another facility.  20 days after leaving hospital rehab he still has significant aphasia and apraxia, and reduced motor control, balance, etc.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fall, Implantable cardiac monitor insertion, Loss of consciousness, Magnetic resonance imaging, Motor dysfunction
Clinical narrative: Severe stroke, which induced a fall when he was home alone.  Last spoke to someone early in the afternoon of the 11th, found unconscious the morning of the 12th, too late for surgical intervention.  Stroke on the left side of the brain, primary impact to communication centers, diagnosed with aphasia and apraxia.  Some impact on control of right side of his body.  Spent 47 days in the hospital back and forth between medical and rehab sides, and afterwards is doing outpatient rehab at another facility.  20 days after leaving hospital rehab he still has significant aphasia and apraxia, and reduced motor control, balance, etc.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swallow study, X-ray
Clinical narrative: Severe stroke, which induced a fall when he was home alone.  Last spoke to someone early in the afternoon of the 11th, found unconscious the morning of the 12th, too late for surgical intervention.  Stroke on the left side of the brain, primary impact to communication centers, diagnosed with aphasia and apraxia.  Some impact on control of right side of his body.  Spent 47 days in the hospital back and forth between medical and rehab sides, and afterwards is doing outpatient rehab at another facility.  20 days after leaving hospital rehab he still has significant aphasia and apraxia, and reduced motor control, balance, etc.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Autopsy, Death
Clinical narrative: No adverse reactions
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: No adverse reactions
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Injection site pruritus
Clinical narrative: FEVER OF 101.4; CHILLS; SEVERE HEADACHE; ICHY RASH AT INJECTION SITE; SYMPTOMS OF RASH; SHAKING; This spontaneous report received from a consumer concerned a 57 year old male. The patient's weight was not reported and height was 73 inches. The patient's concurrent conditions included no alcohol use, and nonsmoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNWON) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced fever of 101.4. On 09-MAR-2021, the subject experienced shaking and chills. On 09-MAR-2021, the subject experienced severe headache. On 09-MAR-2021, the subject experienced ichy rash at injection site. On 09-MAR-2021, the subject experienced symptoms of rash at injection site. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.4. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever of 101.4, shaking and chills, severe headache, and ichy rash at injection site, and the outcome of symptoms of rash at injection site was not reported. This report was non-serious.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site rash, Myalgia, Pyrexia
Clinical narrative: FEVER OF 101.4; CHILLS; SEVERE HEADACHE; ICHY RASH AT INJECTION SITE; SYMPTOMS OF RASH; SHAKING; This spontaneous report received from a consumer concerned a 57 year old male. The patient's weight was not reported and height was 73 inches. The patient's concurrent conditions included no alcohol use, and nonsmoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNWON) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced fever of 101.4. On 09-MAR-2021, the subject experienced shaking and chills. On 09-MAR-2021, the subject experienced severe headache. On 09-MAR-2021, the subject experienced ichy rash at injection site. On 09-MAR-2021, the subject experienced symptoms of rash at injection site. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.4. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever of 101.4, shaking and chills, severe headache, and ichy rash at injection site, and the outcome of symptoms of rash at injection site was not reported. This report was non-serious.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Injection site rash, Pyrexia
Clinical narrative: FEVER OF 101.4; CHILLS; SEVERE HEADACHE; ICHY RASH AT INJECTION SITE; SYMPTOMS OF RASH; SHAKING; This spontaneous report received from a consumer concerned a 57 year old male. The patient's weight was not reported and height was 73 inches. The patient's concurrent conditions included no alcohol use, and nonsmoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNWON) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced fever of 101.4. On 09-MAR-2021, the subject experienced shaking and chills. On 09-MAR-2021, the subject experienced severe headache. On 09-MAR-2021, the subject experienced ichy rash at injection site. On 09-MAR-2021, the subject experienced symptoms of rash at injection site. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.4. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever of 101.4, shaking and chills, severe headache, and ichy rash at injection site, and the outcome of symptoms of rash at injection site was not reported. This report was non-serious.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Tremor
Clinical narrative: FEVER OF 101.4; CHILLS; SEVERE HEADACHE; ICHY RASH AT INJECTION SITE; SYMPTOMS OF RASH; SHAKING; This spontaneous report received from a consumer concerned a 57 year old male. The patient's weight was not reported and height was 73 inches. The patient's concurrent conditions included no alcohol use, and nonsmoker, and other pre-existing medical conditions included patient had no known drug allergies. patient had no drug abuse or illicit drug usage at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNWON) .5 ml, administered on 09-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced fever of 101.4. On 09-MAR-2021, the subject experienced shaking and chills. On 09-MAR-2021, the subject experienced severe headache. On 09-MAR-2021, the subject experienced ichy rash at injection site. On 09-MAR-2021, the subject experienced symptoms of rash at injection site. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.4. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever of 101.4, shaking and chills, severe headache, and ichy rash at injection site, and the outcome of symptoms of rash at injection site was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Syringe issue
Clinical narrative: HALF DOSE RECEIVED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: G200707, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced half dose received. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of half dose received was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: HALF DOSE RECEIVED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: G200707, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced half dose received. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of half dose received was not reported. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: CHILLS; FEVER; HEADACHE; SORE ARM; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included latex allergy, non alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 12:50 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100.9 (unit not specified). On 10-MAR-2021 12:50, the subject experienced sore arm. On 10-MAR-2021 22:00, the subject experienced chills. On 10-MAR-2021 22:00, the subject experienced fever. On 10-MAR-2021 22:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 10-MAR-2021 15:50, was recovering from chills, and fever, and had not recovered from headache. This report was non-serious.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: CHILLS; FEVER; HEADACHE; SORE ARM; This spontaneous report received from a patient concerned a 62 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included latex allergy, non alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no history of drug abuse or illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805022 expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 12:50 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 100.9 (unit not specified). On 10-MAR-2021 12:50, the subject experienced sore arm. On 10-MAR-2021 22:00, the subject experienced chills. On 10-MAR-2021 22:00, the subject experienced fever. On 10-MAR-2021 22:00, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 10-MAR-2021 15:50, was recovering from chills, and fever, and had not recovered from headache. This report was non-serious.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Depressed level of consciousness, Oxygen saturation decreased, Pyrexia
Clinical narrative: Positive COVID19 case post-vaccination, resulting in hospitalization and death.  COVID19 pneumonia, acute hypoxic respiratory failure.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Death, SARS-CoV-2 test positive
Clinical narrative: Positive COVID19 case post-vaccination, resulting in hospitalization and death.  COVID19 pneumonia, acute hypoxic respiratory failure.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Respiratory arrest
Clinical narrative: pt had a cardiac arrest 8 hours after receiving vaccine.  Pt had no prior hx and upon cardiac cath showed not blockages.  The provider states was allergic reaction to medication.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac arrest, Catheterisation cardiac normal, Hypersensitivity
Clinical narrative: pt had a cardiac arrest 8 hours after receiving vaccine.  Pt had no prior hx and upon cardiac cath showed not blockages.  The provider states was allergic reaction to medication.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: HEAVY LEGS; CHILLS; FEVER; SORENESS AND BODY ACHES; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On MAR-2021, the subject experienced heavy legs. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced soreness and body aches. On MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, heavy legs, soreness and body aches, chills and nausea was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Limb discomfort, Nausea, Pain, Pyrexia
Clinical narrative: HEAVY LEGS; CHILLS; FEVER; SORENESS AND BODY ACHES; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On MAR-2021, the subject experienced heavy legs. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced soreness and body aches. On MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, heavy legs, soreness and body aches, chills and nausea was not reported. This report was non-serious.